Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.76 USD | -1.66% | -3.99% | -41.16% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.16% | 781M | |
+4.31% | 106B | |
+6.87% | 23.47B | |
-14.21% | 21.9B | |
-6.73% | 18.77B | |
-38.55% | 17.85B | |
-8.40% | 16.78B | |
+7.10% | 14.41B | |
+38.76% | 12.86B | |
+323.80% | 8.78B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Transcript : Sage Therapeutics, Inc., Q1 2023 Earnings Call, May 02, 2023